My Stocks Explore Events Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Live today
{{event.ticker}} @{{event.event_utc_datetime | date:'h:mm a'}}
{{market.market_short_name}} {{market.last_price | number : 2}}

Want to join the conversation?

$AEP {{ '2016-07-28T19:57:15+0000' | timeago}} • Webcast

$AEP said its total debt to capital ratio grew by 0.3% during 2Q16 and remained healthy at 54%. The company's credit metrics, FFO interest coverage, and FFO to debt are solidly in the BBB and Baa1 range at 5.6 times and 20.2%, respectively. $AEP's qualified pension funding remained unchanged for 2Q16 at 94%.

User Josh Allan {{ '2016-10-27T15:39:01+0000' | timeago}}

Jeff Bezos, my inspiration next to Steve Jobs is going to review the Everything Store $AMZN's financial results today after hours. As an investor/user, I like Amazon Prime and it's success over several parts of the world. What's your take on Amazon?

User RC xNair {{ '2016-10-27T13:31:32+0000' | timeago}}

Of all the Wall St firms out there, Goldman Sachs $GS is the most revered for the way they're run - hiring the best, highly competitive, a closely-knit peer group and making tons of profits for the shareholders. An interesting interview of its CEO Llyod Blankfein by Carlyle groups chief David Rubenstein

User Ramesh Raju {{ '2016-10-27T10:38:07+0000' | timeago}}

Deutsche Bank posts Q3 net profit of 278 million euros.

User Vishnu Beri {{ '2016-10-27T01:52:28+0000' | timeago}}

Great results from $TSLA, however the question remains if Tesla can continue to scale up to produce the cars in the quantity it promises. Model 3 numbers need to be in multiples of what they are producing right now. Wish them the best, will keep an eye as I am still not convinced that they can scale easily.

User Michael Michael {{ '2016-10-26T23:46:35+0000' | timeago}}

Watching $TSLA Oct 28th $215 Calls for possible entry

$SYK {{ '2016-10-27T20:41:29+0000' | timeago}} • Announcement

$SYK said that in 3Q16 its Orthopaedics segment net sales rose 5.6% as reported and 5.3% in constant currency YoverY. MedSurg net sales rose 33% as reported and in constant currency to $1.3Bil for the quarter. Neurotechnology and Spine net sales rose 9.7% as reported and 8.7% in constant currency compared a year ago.

$SYK {{ '2016-10-27T20:37:57+0000' | timeago}} • Announcement

$SYK expects 2016 organic sales growth to be in the range of 6.0-6.5% and adjusted EPS to be in the range of $5.75-$5.80 compared to the prior guidance of $5.70-5.80. For 4Q16, $SYK expects adjusted EPS to be in the range of $1.73-1.78. The company expects the impact of FX on adjusted EPS to be neutral in 4Q16.

$GOOGL {{ '2016-10-27T20:35:51+0000' | timeago}} • Announcement

In 3Q16, $GOOGL posted revenues of $22.2Bil in the Google segment, an increase from $18.5Bil in 3Q15. The Other Bets segment, which comprises of all the other businesses owned by the company,  had revenues of $197MM, an increase from $141MM last year.

$SYK {{ '2016-10-27T20:34:09+0000' | timeago}} • Announcement

Medical technology company $SYK posted higher 3Q16 earnings, helped by higher sales. Net income for the quarter rose 17.94% to $355MM or $0.94 per share from $301MM or $0.79 per share a year ago. Revenue for the quarter rose 17% to $2.83Bil. Excluding items, $SYK earned $1.39 per share.

$VRSN {{ '2016-10-27T20:32:06+0000' | timeago}} • Announcement

During 3Q16, $VRSN repurchased 2.2MM shares of its common stock for $177MM. At Sept. 30, 2016, $589MM remained available and authorized under the current share repurchase program which has no expiration. The company ended the quarter with cash, cash equivalents and marketable securities of $1.8Bil, a decrease of $158MM from year-end 2015.